31338-32-6

Usage

Uses

Used in Psychotherapy Applications:
1-(3,4-Difluorophenyl)-2-aminopropane is used as a potential therapeutic agent for enhancing empathy, closeness, and euphoria in psychotherapy sessions. Its ability to release serotonin makes it a candidate for exploring new treatment options for various mental health conditions.
Used in Research and Development:
In the scientific community, 1-(3,4-Difluorophenyl)-2-aminopropane serves as a research compound for studying the mechanisms of action and potential applications of substituted amphetamines. This helps in understanding the effects of similar compounds on human cognition, emotion, and behavior.
Used in Drug Regulation and Policy Development:
Due to its psychoactive properties and potential for abuse, 1-(3,4-Difluorophenyl)-2-aminopropane is used as a reference compound in the development of drug regulation policies and legal frameworks. This aids in the identification, control, and prevention of the abuse of designer drugs and their potential harmful effects on public health.

Upstream product

• 34036-07-2 3,4 difluorobenzaldehyde 

Downstream Products

• 1062587-68-1 1-(3,4-difluorophenyl)-2-ethylaminopropane hydrochloride 
• 848121-95-9 ethyl 9,10-difluoro-6-methyl-2-oxo-1,6,7,11b-tetrahydro-2H-pyrido[2,1-a]isoquinoline-3-carboxylate 
• 848121-96-0 ethyl 9,10-difluoro-6-methyl-2-oxo-6,7-dihydro-2H-pyrido[2,1-a]isoquinoline-3-carboxylate 
• 848121-97-1 9,10-difluoro-6-methyl-2-oxo-6,7-dihydro-2H-pyrido[2,1-a]isoquinoline-3-carboxylic acid 
• 848121-92-6 8,9-difluoro-5-methyl-2,3,6,10b-tetrahydro-5H-[1,3]oxazolo[2,3-a]isoquinoline-2,3-dione 
• 848121-93-7 6,7-difluoro-3-methyl-3,4-dihydroisoquinoline 
• 848121-91-5 N-[2-(3,4-difluorophenyl)-1-methylethyl]formamide 
• 1018678-52-8 4-amino-N-(1-(3,4-difluorophenyl)propan-2-yl)-2-(trifluoromethyl)nicotinamide 

Relevant academic research and scientific papers

FLUORINE-SUBSTITUTED AMPHETAMINES AND AMPHETAMINE DERIVATIVES AND USE THEREOF

A fluorine-substituted amphetamine or amphetamine derivative with the formula (I): where at least one of the residues R1 or R2 is different from H and Ph is a phenyl ring, which is substituted with fluorine in at least one position or the residues R1 and R2 independently of one another are H or are different from H and Ph is a phenyl ring, which is substituted with fluorine in at least three positions or the residues R1 and R2 independently of one another are H or are different from H and Ph is a phenyl ring, which is substituted with fluorine in at least one position and has a substituent different from H in at least one other position.

Chiral DNA gyrase inhibitors. 3. Probing the chiral preference of the active site of DNA gyrase. Synthesis of 10-fluoro-6-methyl-6,7-dihydro-9- piperazinyl-2H-benzo[a]quinolizin-20-one-3-carboxylic acid analogues

In pursuit of an apparent literature anomaly, S- and R-6-methyl-6,7- dihydro-2H-benzo[a]-quinolizin-2-one-3-carboxylic acids (12 and 22) were synthesized by an unambiguous route from optically active norephedrines, and their antibacterial potencies were measured. Against Gram-negative microorganisms and DNA gyrase a preference for S-absolute configuration was found whereas R-absolute stereochemistry was more active against Gram-positives. These results are in partial conflict with an earlier report. In an attempt to enhance potency, racemic 10-fluoro-9-piperazinyl (35) and related analogues were synthesized by a novel route. The latter analogues were surprisingly unimproved in potency. The implications of these findings are briefly discussed.